TCT-582 Eighteen Month Clinical and Imaging Results from the DESSOLVE I First-in-Human Trial of the MiStent® SES with Absorbable Polymer

The MiStent SES (Micell Technologies, Durham, NC) is an investigational DES characterized by use of crystalline sirolimus and a fully absorbable polymer on a thin strut (64um) cobalt-chromium stent. The stent coating is eliminated from the stent in 45-60 days with full absorption of the polymer by